- Entry
- $8.07
- Final
- $7.78 -3.6%
- Target
- —
- Score
- -0.36
Pressure will start to build around 3.70-3.80. Fintel reporting short interest around 37% with 8 days to cover this thing may actually blow. World renowned doctor Dr. Pat Soon-Shiong announced a few days ago that they have some major announcements this week, followed by Saudi FDA granting approval to their ANKTIVA + checkpoint inhibitor the first approved chemotherapy-free immunotherapy that activates both natural killer cells and killer T cells, heralding the era of immunotherapy 2.0. This thing has the catalyst …
— ORIGINAL POST ·
IBRX possibly working its way to an epic short squeeze?
· r/Shortsqueeze
· Jan 15, 2026